| Record ID | marc_loc_updates/v36.i11.records.utf8:4948324:1644 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_updates/v36.i11.records.utf8:4948324:1644?format=raw |
LEADER: 01644cam a22004094a 4500
001 2001026439
003 DLC
005 20080311120706.0
008 010509s2002 njua b 001 0 eng
010 $a 2001026439
020 $a0896036731 (alk. paper)
035 $a(DNLM)101095681
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aRC280.B8$bH645 2002
060 10 $aWP 870$bE557 2001
082 00 $a616.99/449061$221
245 00 $aHormone therapy in breast and prostate cancer /$cedited by V. Craig Jordan and Barrington J.A. Furr.
260 $aTotowa, N.J. :$bHumana Press,$cc2002.
300 $axiv, 420 p. :$bill. ;$c24 cm.
440 0 $aCancer drug discovery and development
504 $aIncludes bibliographical references and index.
650 0 $aBreast$xCancer$xHormone therapy.
650 0 $aProstate$xCancer$xHormone therapy.
650 0 $aEstrogen$xAntagonists$xTherapeutic use.
650 0 $aAntiandrogens$xTherapeutic use.
650 12 $aBreast Neoplasms$xdrug therapy.
650 12 $aProstatic Neoplasms$xdrug therapy.
650 22 $aAndrogen Antagonists$xtherapeutic use.
650 22 $aAntineoplastic Agents, Hormonal$xtherapeutic use.
650 22 $aSelective Estrogen Receptor Modulators$xtherapeutic use.
650 22 $aTamoxifen$xtherapeutic use.
700 1 $aJordan, V. Craig$q(Virgil Craig)
700 1 $aFurr, B. J. A.
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/fy032/2001026439.html
856 42 $3Book review (E-STREAMS)$uhttp://www.e-streams.com/es0606/es0606_2516.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0825/2001026439-d.html